Concepedia

Hadi Poormoghim

HP

Statistics

Publications

5

Citations

98

H-Index

5

Active since

2009

Affiliations

Firoozgar General Hospital(Current)

Iran University of Medical Sciences

Lorestan University of Medical Sciences

Hadi Poormoghim is an author at Firoozgar General Hospital specializing in life sciences, immunopathology, and autoimmunity.

Publications per year

2009–2022

5

Publications

5

KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population

Nader Tajik, Farhad Shahsavar, Hadi Poormoghim et al. · International Journal of Immunogenetics · 2011 · 28 citations

, , +17

Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients.

Tahereh Mousavi, Hadi Poormoghim, Nader Tajik et al. · PubMed · 2009 · 23 citations

, , +14

Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.

Tahereh Mousavi, Hadi Poormoghim, Nader Tajik et al. · PubMed · 2010 · 20 citations

, , +17

Systemic sclerosis and calcinosis cutis: response to rituximab

Hadi Poormoghim, Elham Andalib, Alireza Almasi et al. · Journal of Clinical Pharmacy and Therapeutics · 2015 · 14 citations

, , +10

Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis

Paria Bayati, Hadi Poormoghim, Nazanin Mojtabavi · Biomarker Insights · 2022 · 13 citations · Full text

, , +17

1–5 of 5